Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/Ib Study Evaluating Safety and Efficacy of PRGN-3005 UltraCAR-T® (Autologous CAR T Cells) in Advanced Stage Platinum Resistant Ovarian Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03907527
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:09.015974+00:00
Published At
2024-11-08T00:00:00+00:00
Record Updated At
2024-11-08
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Platinum-Resistant Fallopian Tube Carcinoma", "Platinum-Resistant Ovarian Carcinoma", "Platinum-Resistant Primary Peritoneal Carcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma", "Refractory Fallopian Tube Carcinoma", "Refractory Ovarian Carcinoma", "Refractory Primary Peritoneal Carcinoma", "Stage III Fallopian Tube Cancer AJCC V8", "Stage III Ovarian Cancer AJCC V8", "Stage III Primary Peritoneal Cancer AJCC V8", "Stage IIIA Fallopian Tube Cancer AJCC V8", "Stage IIIA Ovarian Cancer AJCC V8", "Stage IIIA Primary Peritoneal Cancer AJCC V8", "Stage IIIA1 Fallopian Tube Cancer AJCC V8", "Stage IIIA1 Ovarian Cancer AJCC V8", "Stage IIIA2 Fallopian Tube Cancer AJCC V8", "Stage IIIA2 Ovarian Cancer AJCC V8", "Stage IIIB Fallopian Tube Cancer AJCC V8", "Stage IIIB Ovarian Cancer AJCC V8", "Stage IIIB Primary Peritoneal Cancer AJCC V8", "Stage IIIC Fallopian Tube Cancer AJCC V8", "Stage IIIC Ovarian Cancer AJCC V8", "Stage IIIC Primary Peritoneal Cancer AJCC V8", "Stage IV Fallopian Tube Cancer AJCC V8", "Stage IV Ovarian Cancer AJCC V8", "Stage IV Primary Peritoneal Cancer AJCC V8", "Stage IVA Fallopian Tube Cancer AJCC V8", "Stage IVA Ovarian Cancer AJCC V8", "Stage IVA Primary Peritoneal Cancer AJCC V8", "Stage IVB Fallopian Tube Cancer AJCC V8", "Stage IVB Ovarian Cancer AJCC V8", "Stage IVB Primary Peritoneal Cancer AJCC V8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-08"
protocolSection.identificationModule.nctId
"NCT03907527"
protocolSection.identificationModule.officialTitle
"Phase I/Ib Study Evaluating Safety and Efficacy of PRGN-3005 UltraCAR-T\u00ae (Autologous CAR T Cells) in Advanced Stage Platinum Resistant Ovarian Cancer Patients"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Platinum-Resistant Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage III Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage III Primary Peritoneal Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Primary Peritoneal Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA1 Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA1 Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA2 Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA2 Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Primary Peritoneal Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Primary Peritoneal Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IV Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IV Primary Peritoneal Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Primary Peritoneal Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Fallopian Tube Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Ovarian Cancer AJCC V8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Primary Peritoneal Cancer AJCC V8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.